Active Funding Opportunities
Nucleic Acid Sequencing
-
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development
NOT-HG-21-016 -
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
NOT-HG-21-017 -
Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Nucleic Acid Sequencing Technology Innovation and Early Development
NOT-HG-21-019
-
RFA-HG-20-014 Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
Expiration Date: Jun 25, 2022
-
RFA-HG-20-015 Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed)
Expiration Date: Jun 25, 2022
-
RFA-HG-20-016 Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed)
Expiration Date: Jun 25, 2022
Genomic Technology Development
Expired Funding Opportunities
Genomic Technology Development
Program Staff

- Program Director Genome Technology Program
- Division of Genome Sciences

- Program Director
- Division of Genome Sciences
Last updated: April 1, 2020